Search

Your search keyword '"Alkistis Kyra Panteliadou"' showing total 6 results
Start Over Author "Alkistis Kyra Panteliadou"
6 results on '"Alkistis Kyra Panteliadou"'

1. P1311: LONG-TERM SAFETY AND EFFICACY OF EXTRACORPOREAL PHOTOPHERESIS AS EARLY SECOND-LINE TREATMENT FOR PATIENTS WITH STEROID-DEPENDENT OR REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE.

Author

Eleni Gavriilaki, Ioannis Batsis, Eleni Papchianou, Georgios Karavalakis, Alkistis Kyra Panteliadou, Zoi Bousiou, Despina Mallouri, Christos Demosthenous, Aikaterini Soulani, Asimina Bouinta, Anna Vardi, Evangelia Yannaki, Nikolaos Spyridis, Damianos Sotiropoulos, Achilles Anagnostopoulos, and Ioanna Sakellari

Subjects
Diseases of the blood and blood-forming organs, RC633-647.5
Published
2023
Full Text
View/download PDF

2. PB2261: DECREASE IN NEUTROPHIL-LYMPHOCYTE RATIO IMPACTS OVERALL SURVIVAL OF ADULT PATIENTS WITH HODGKIN LYMPHOMA AFTER ANTI-PD1 TREATMENT

Author

Christos Varelas, Eleni Gavriilaki, Panagiotis Dolgiras, Michail Iskas, Chrysavgi Lalagianni, Syrigou Antonia, Maria Papathanasiou, Anastasia Marvaki, Chrysanthi Vadikolia, Despina Mallouri, Ioannis Batsis, Zoi Bousiou, Anna Vardi, Georgios Karavalakis, Nikolaos Spyridis, Alkistis Kyra Panteliadou, Marianna Masmanidou, Evangelia Yannaki, Georgios Arsos, Triantafillos Geroukis, Niki Stavrogianni, and Ioanna Sakellari

Subjects
Diseases of the blood and blood-forming organs, RC633-647.5
Published
2023
Full Text
View/download PDF

3. Autoimmune Cytopenias Developing Late Post Alemtuzumab-Based Allogeneic Stem Cell Transplantation: Presentation of Short Case Series from a Transplant Center

Author

Rebecca Lloyd, Emmanouil Nikolousis, Bhuvan Kishore, Richard Lovell, Paneesha Shankara, Nervana Abou Zeid, Claire Horgan, Alkistis Kyra Panteliadou, Graham McIlroy, Evgenia Xenou, Maria Kaparou, Kathleen Holder, Vidhya Murthy, and Alexandros Kanellopoulos

Subjects
Medicine
Abstract

Stem cell transplantation remains the curative option for many patients with hematological malignancies. The long-term effects of these treatments on the patients and their immune systems have been extensively investigated, but there remains a paucity of data regarding autoimmune manifestations post-transplant, although these effects are well recognized. Herein we present the clinical picture and therapeutic approach in three patients (cases 1–3), with varied presentations of autoimmune disease post-transplant. Case 1 exhibited autoimmune hemolytic anemia and other autoimmune manifestations (serositis, thyroiditis), that were probably linked to graft versus relapsed leukemia effect. Cases 2 and 3 had pure red white cell aplasia and pure red cell aplasia, respectively, which were associated with hyperglobulinemia and a clonal T cell expansion.

Published
2020
Full Text
View/download PDF

4. International validation of the EORTC QLQ‐CLL17 questionnaire for assessment of health‐related quality of life for patients with chronic lymphocytic leukaemia

Author

Simone, Oerlemans, Fabio, Efficace, Jacobien M, Kieffer, Charalampia, Kyriakou, Aliki, Xochelli, Kerstin, Levedahl, Duska, Petranovic, Fabio Cardoso, Borges, Anne, Bredart, Omar, Shamieh, Laimonas, Gziskevicius, Jens, Lehmann, Christian W, Scholz, Giovanni, Caocci, Stefano, Molica, Kostas, Stamatopoulos, Alkistis-Kyra, Panteliadou, Maria, Papaioannou, Waleed, Alrjoob, Panagiotis, Baliakas, Richard, Rosenquist, Sandra, Malak, Ana, Miranda, Kim, Cocks, Lonneke, van de Poll-Franse, and Medical and Clinical Psychology

Subjects
PRO, Psychometrics, questionnaire, QLQ-C30, Pain, Reproducibility of Results, Hematology, FEAR, psychometric properties, Leukemia, Lymphocytic, Chronic, B-Cell, THERAPY, EORTC, TRIALS, quality of life, Surveys and Questionnaires, CHLORAMBUCIL, LYMPHOMA, Humans, CRITERIA, symptoms, REPORTED OUTCOMES, RITUXIMAB, chronic lymphocytic leukaemia
Abstract

Selecting the most appropriate chronic lymphocytic leukaemia (CLL) treatment is challenging. Patient-reported health-related quality of life (HRQoL) is therefore a critical aspect to consider. This international study by the European Organization for Research and Treatment of Cancer (EORTC) tested the psychometric properties of a newly developed measure for CLL patients: the EORTC QLQ-CLL17 to supplement the core questionnaire (EORTC QLQ-C30). Patients with CLL (n = 341) from 12 countries completed the QLQ-C30, QLQ-CLL17 and a debriefing questionnaire. Sociodemographic and clinical data were recorded from medical records. A high percentage (30%-66%) reported symptoms and/or worries (e.g. aches/pains in muscles, lack of energy and worry/fears about health). Confirmatory factor analysis showed an acceptable to good fit of the 17 items on the three scales (i.e. symptom burden, physical condition/fatigue and worries/fears about health and functioning). Completion took on average 8 min. Test-retest and convergent validity was demonstrated. The QLQ-CLL17 differentiated between patients with an Eastern Cooperative Oncology group (ECOG) performance of 0 versus 1-3 (p's < 0.01 and clinically relevant). The newly developed EORTC QLQ-CLL17 will increase sensitivity of HRQoL assessment in patients with CLL. Implementation of this questionnaire both in clinical research and practice will help to generate unique clinically relevant data to better inform CLL treatment decision-making.

Published
2022

5. Development of Classic Hodgkin Lymphoma after successful treatment of primary mediastinal large b-cell lymphoma: results from a well-defined database

Author

Fotios Panitsas, Christina Kalpadakis, Vassilios Xanthopoulos, Gerassimos Tsourouflis, Kostas Konstantopoulos, Eleftheria Hatzimichael, Stamatis Karakatsanis, Maria Dimou, Eleni Variamis, Maria Papaioannou, Theodoros P. Vassilakopoulos, Gerassimos A. Pangalis, Sotirios G. Papageorgiou, Ioannis Kotsianidis, Meletios A. Dimopoulos, Alexia Piperidou, Ioannis Batsis, Ioannis Vassilopoulos, Evdoxia Hadjiharissi, Themistoklis Karmiris, Theoni Leonidopoulou, Maria K. Angelopoulou, Alkistis-Kyra Panteliadou, Eirini Katodritou, Panayiotis Panayiotidis, Dimitrios Boutsis, Maria Kotsopoulou, Niki Stavroyianni, Evgenia Verigou, and Michail Michail

Subjects
Oncology, Adult, Male, Cancer Research, medicine.medical_specialty, Databases, Factual, MEDLINE, Mediastinal Neoplasms, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Primary Mediastinal Large B-Cell Lymphoma, Survival rate, Hematology, business.industry, Follow up studies, medicine.disease, Prognosis, Hodgkin Disease, Lymphoma, Survival Rate, Hodgkin lymphoma, Female, Lymphoma, Large B-Cell, Diffuse, business, Follow-Up Studies
Published
2020

6. Autoimmune Cytopenias Developing Late Post Alemtuzumab-Based Allogeneic Stem Cell Transplantation: Presentation of Short Case Series from a Transplant Center

Author

Emmanouil Nikolousis, Bhuvan Kishore, Alexandros Kanellopoulos, Graham McIlroy, Vidhya Murthy, Nervana Abou Zeid, Rebecca Lloyd, Richard Lovell, Claire Horgan, Evgenia Xenou, Kathleen Holder, Paneesha Shankara, Alkistis Kyra Panteliadou, and Maria Kaparou

Subjects
Adult, Male, Biomedical Engineering, Hyperglobulinemia, lcsh:Medicine, Pure red cell aplasia, autoimmune disease, Thyroiditis, Autoimmune Diseases, 03 medical and health sciences, 0302 clinical medicine, graft versus host disease, Medicine, Humans, Transplantation, Homologous, Alemtuzumab, t cells, Autoimmune disease, Transplantation, Case Study, business.industry, lcsh:R, Hematopoietic Stem Cell Transplantation, Cell Biology, bone marrow transplant, Middle Aged, medicine.disease, hematopoietic stem cells, Graft-versus-host disease, 030220 oncology & carcinogenesis, Immunology, Female, Autoimmune hemolytic anemia, business, 030215 immunology, medicine.drug
Abstract

Stem cell transplantation remains the curative option for many patients with hematological malignancies. The long-term effects of these treatments on the patients and their immune systems have been extensively investigated, but there remains a paucity of data regarding autoimmune manifestations post-transplant, although these effects are well recognized. Herein we present the clinical picture and therapeutic approach in three patients (cases 1–3), with varied presentations of autoimmune disease post-transplant. Case 1 exhibited autoimmune hemolytic anemia and other autoimmune manifestations (serositis, thyroiditis), that were probably linked to graft versus relapsed leukemia effect. Cases 2 and 3 had pure red white cell aplasia and pure red cell aplasia, respectively, which were associated with hyperglobulinemia and a clonal T cell expansion.

Published
2020

Catalog

Books, media, physical & digital resources
See catalog results